CAR-T Safety and Efficacy Endpoints: A Checklist for Preclinical Development

Genetic Engineering & Biotechnology News

CAR-T therapies have shown great promise for the treatment of certain types of cancer. David Harris, PhD, Research Director, explains how a one-size-fits-all testing approach with these innovative therapies might not be a wise strategy.